Dr. Concetta Iside is a biomedical scientist with a PhD in Translational Medicine and research experience in cardiovascular, cerebrovascular, and metabolic diseases. Her academic and scientific activities have been carried out at the University of Salerno, IRCCS SYNLAB SDN in Naples, and the University of Campania “Luigi Vanvitelli”. She has been involved in institutionally funded research projects, including activities as Principal Investigator, and has also gained university teaching experience. Her research focuses on the molecular mechanisms underlying vascular and endothelial dysfunction, with particular interest in oxidative stress, epigenetic regulation, hypertension, atherosclerosis, diabetes, and cardiometabolic disease. Her scientific activity also includes biomarker discovery, Drug Discovery, and the preclinical evaluation of potential therapeutic strategies. Her work follows a translational approach integrating cellular and molecular biology, biochemical and functional assays, advanced in vitro models, and in vivo murine models of cardiovascular and metabolic disease, with the aim of identifying novel molecular targets and potential diagnostic and therapeutic applications.